Your browser doesn't support javascript.
loading
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma.
Vogl, Dan T; Martin, Thomas G; Vij, Ravi; Hari, Parameswaran; Mikhael, Joseph R; Siegel, David; Wu, Ka Lung; Delforge, Michel; Gasparetto, Cristina.
Afiliação
  • Vogl DT; a Abramson Cancer Center , University of Pennsylvania, Perelman School of Medicine , Philadelphia , PA , USA.
  • Martin TG; b Adult Leukemia and Bone Marrow Transplantation Program , University of California San Francisco , San Francisco , CA , USA.
  • Vij R; c Bone Marrow Transplantation and Leukemia Section, Department of Medicine , Washington University School of Medicine , St. Louis , MO , USA.
  • Hari P; d Adult Blood and Marrow Transplant Program , Medical College of Wisconsin , Milwaukee , WI , USA.
  • Mikhael JR; e Division of Hematology and Medical Oncology , Mayo Clinic , Scottsdale , AZ , USA.
  • Siegel D; f John Theurer Cancer Center , Hackensack University Medical Center , Hackensack , NJ , USA.
  • Wu KL; g Department of Hematology , ZNA Stuivenberg , Antwerp , Belgium.
  • Delforge M; h Department of Hematology , University Hospital Leuven , Leuven , Belgium.
  • Gasparetto C; i Division of Medicine-Cell Therapy and Hematologica , Duke University Medical Center , Durham , NC , USA.
Leuk Lymphoma ; 58(8): 1872-1879, 2017 08.
Article em En | MEDLINE | ID: mdl-28140719
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Treonina / Ácidos Borônicos / Inibidores de Proteassoma / Mieloma Múltiplo Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Treonina / Ácidos Borônicos / Inibidores de Proteassoma / Mieloma Múltiplo Idioma: En Ano de publicação: 2017 Tipo de documento: Article